SlideShare a Scribd company logo
CARDIOVASCULAR CONDITIONS/DISEASES
COURSE OUTLINE
1. Hypertension
2. Heart failure/Congestive cardiac failure
3. Ischaemic heart diseases
4. Pericarditis Deep venous thrombosis (DVT)
5. Myocarditis Rheumatic heart disease
6. Endocarditis Alcoholic heart disease
7. Cardiomyopathies
8. Congenital abnormalities Aortic aneurysm
9. Pulmonary oedema Nutritional H Disease
10. Pulmonary embolism
General Signs and Symptoms of CVS D/Os
1. Dyspnoea-Its awareness of breathlessness on
exertion which is frequently the first symptom of HF.
It is hard to distinguish from dyspnoea due to lung
d’se.
• Patients with HF take rapid shallow breath,
wheezes but excessive use of muscles of
respiration is uncommon.
2. Cough-Repeatitive unproductive cough in the
presence of pulmonary oedema is an important
symptom in left sided heart failure.
3. Wheezing-when it becomes prominent its called
cardiac asthma.
General Signs and Symptoms cont’d
4. Orthopnoea-its dyspnoea that occurs when a
patient is lying down flat and improves upon sitting
up or breathlessness which prevents a patient from
lying flat.
• Lying down rises the right atrial pressure and the
right ventricular out put forcing more blood into
lungs. Breathlessness is due to stiffness of the
congested lungs & partly due to direct stimulation
of the fine nerve endings around the alveoli.
• Orthopnoea suggest left ventricular failure or
mitral valve stenosis but may also accompany
COPD
S/S CONT’D
5. Paroxysmal nocturnal dyspnoea-episodes of
sudden dyspnoea and orthopnoea that wakes up a
patient from sleep, usually 1-2 hours after going to
sleep. The patient has to sit up for relieve & may be
associated with wheezing and cough.
• It suggests Left ventricular HF or mitral valve
stenosis & may mimic nocturnal asthmatic attacks
6. Chynestokes respiration(periodic breathing)
• Common in severe HF but can also occur in elderly
patients without any evidence of HF particularly
during sleep.
S/S CONT’D
7. Peripheral Oedema (pedal/ankle/tibial oedema)
• Accumulation of fluids in tissues/interstsial spaces
• Occurs in HF due to excessive salts & water
retention. Found mainly in the feet & ankles in
ambulant patients as this site is largely determined
by gravity. Pressure with a thumb if sustained will
displace the fluid leaving a pit hence it is referred
as bilateral, non tender pitting pedal oedema
• In severe HF fluid may accumulate in pleural and
abdominal cavity causing pleural effusion and
ascites respectively
S/S CONT’D
8. Chest pain-cardinal symptom of Ischaemic heart
diseases e.g Angina pectoris& myocardial infarction
The stabbing squeezing tight chest pain felt
momentarily at cardiac apex is referred to as
Precordial catch. It is often indicated by a finger
pointing below the left apex beat.
Chest pain can also signify lung or muscular system
problem
9. Pleural pain- feature/symptom of pulmonary
infarction which often complicates HF
S/S CONT’D
11. Hepatic Pain- Felt in the right epigastrium and
some times a sign of acute or worsening HF. It is due
to hepatic distension from rise in central venous
pressure. It can be due to straining of the liver capsule
Coz of blood accumulation in liver RHF.
12. Palpitations-awareness of heart beat as a result of
exercise or anxiety. Occurs due to increased
catecholamine secretion (adrenaline and
noradrenaline) and sympathomimetic drugs.
13. Others s/s include; Easy fatigability, Exercise
intolerance
Classification of Heart conditions
1. Disorders of heart rate and rhythm e.g
Tachycardia and Bradycardia
2. Ischaemic heart diseases e.g angina pectoris & MI
3. Valvlar heart diseases e.g Rheumatic heart
disease, Infective endocarditis (sub acute bacterial
endocarditis)
4. Vascular heart diseases e.g HTN, peripheral
arterial diz like arteritis, aortic lessions,
thromboembolism etc
5. Diseases of the myocardium e.g myocarditis,
cardiomyopathies (dilated/restrictive), EMF
Classification cont’d
6. Congenital heart defects e.g
• Patent ductus arteriosus (failure of ductus to close
at birth)= Ductus arteriosus shunt/communication
btn P.A & Aorta during foetal circulation/uterus
• Atrial septal defect=communication btn atria (R/L)
• Ventricular septal defect=communication btn
ventricles (R/L)
• Coarcitation of the aorta=narrowing of the aorta
usually just distal to the origin where D.A inserts.
7. Diseases of the blood vessels e.g atherosclerosis,
arteritis, phlebitis
Classification cont’d
8. Pericardial diseases e.g Pericarditis, Pericardial
effusion, constrictive pericarditis
9. Syphilitic heart diseases
10. Heart diseases secondary to lung disease e.g cor-
pulmonale
Cheynestoke respiration= Breathing commencing
with shallow & slow respn which decreases in rate &
depth & ceases for 10 seconds before commencing
(periodic breathing)
Effects of CVS Diz of body fxns
Diseases of the heart causes its inability to produce an
out put sufficient to meet patients’ needs. This affects
the body functions causing a number of
manifestations.
CVS e.g Pallor of mucus membranes, cyanosis,
tachycardia and chest pain
RS e.g cough, dyspnoea, pulmonary congestion,
haemoptysis
Effects of CVS CONT’D
NS e.g Insomnia, amnesia, mental changes &
delusions, delirium
GIT e.g Anorexia, dyspepsia, flatulence, constipation,
liver congestion
Urinary system e.g diminished urine output,
albuminuria
General e.g Oedema, Ascites and Pleural effusion
CARDIAC FAILURE/HEART FAILURE
By Frank.s
PRESENTATION OUTLINE
1. Definition
2. Risk factors
3. Types of HF
4. Sign and symptoms
5. Complications
6. Investigations
7. Differentials
8. Management
Definitions of HF
1. It’s a condition in which an abnormality of
myocardial fxn is responsible for the inability of the
ventricles to deliver adequate quantities of blood
to metabolizing tissues at rest or during normal
activity. It describes a state when the heart cant
maintain adequate cardiac out put and it does so
at high filling pressures.
2. CCF is a condition where the heart muscle
becomes weak and is unable to pump sufficient
oxygenated blood to meet the metabolic needs of
the tissues.
Definitions cont’d
3. Inadequate cardiac output for the body’s needs
despite adequate venous return-may be due to failure
of the left or right ventricles.
Types of HF
1. Right sided HF= results in a back flow of blood in
the venous circulation producing liver enlargement
and oedema in the extremities.
2. Left sided HF= results in a back flow of blood in the
pulmonary circulation, producing pulmonary
oedema
3. Biventricular HF/CCF= Affects both sides/long
term
Types of HF cont’d
• When RV fails to perform properly, the RA becomes
distended leading to stasis in the venous system.
• The pressure in the superior and inferior venacava
rises.
• The veins in the neck becomes distended (raised
jugular venous pressure-JVP)
• The liver becomes engorged and legs become
oedematous, this is known as CCF.
Causes of HF/CCF
• Coronary heart diseases
• Valvular heart diseases e.g rheumatic heart diz
• Cardiomyopathies
• Severe anaemia Myocardial infarction
• Systemic HTN Chronic respiratory diz
• Cardio toxicity arising from alcoholism
• Unknown/idiopathic Congenital heart defects
• Hyperthyroidism
• Aortic stenosis
• Post viral infections
Risk factors of HF/CCF
• Old age
• Family history/predisposition
• Lack of regular physical exercises
• Obesity/over weight
• High fat/high salt intake
• Sedentary life style
• Drugs like Aminophylline
• Liver failure and Kidney failure
• Pregnancy, Excessive Alcohol, Smoking
• Abnormal pulse rhythm (Arthymias)
Signs and symptoms of HF
• Palpitations, cough , weakness
• Rapid pulse, gallop rhythm
• Dependent oedema/swelling in the ankles
• Raised jugular venous pressure (JVP)
• Enlarged tender liver (right abdominal pain due to
stretching of liver capsule)
• Orthopnea, paroxysmal nocturnal DIB, tachycardia
• Exertional dyspnoea, fatigue, periodic breathing
• Basal crepitations
• Breathlessness & progressively decrease in effort
tolerance Cardiac cachexia-Excessive wasting
Complications of HF
• Cerebral symptoms e.g confusion, difficult in
concentration, impaired memory and headache
• Oliguria i.e diminished urine out put due to renal
failure
• GIT symptoms e.g dyspepsia, nausea, heart burn,
vomiting, anorexia due to congestion of the
stomach and intestines
• Respiratory failure with marked haemoptysis due
to pulmonary infarcts in the lungs as a result of
pulmonary congestion
• Ascites and pleural effusion
Differential diagnosis
• Severe anaemia
• Protein energy malnutrition (PEM)
• Nephrotic syndrome
• Asthma Renal failure, Liver failure/cirrhosis
• Severe pneumonia/Pulmonary diseases
Investigations
• Chest x-ray to rule out cardiomegaly/P.Oedema/LVF
• Blood for CBC/FBC, TPHA/RPR for syphilis
• Echocardiogram and ECG
• Lipid profile (LDL/HDL/Triglycerides)
• RFTs (Urea/creatinine/electrolytes), LFTs
Management of HF/CCF
Aims of mgt/Principles of mgt
1. To relieve symptoms
2. To improve exercise tolerance
3. To reduce incidences of acute exacerbations
4. To reduce hospitalization and mortality
5. To eradicate risk/precipitating factors e.g anaemia
6. Reduction of the work load imposed on the heart
by reducing obesity and having bed rest
7. Reduce salt intake and water retention
Supportive Mgt
• Bed rest with the head of the bed elevated when
symptoms are severe
• Prop up patient in sitting up position/cardiac bed
• Reduce weight in obese patients
• Limit salt/sodium intake
• Stop smoking
• Moderate physical exercises when s/s are mild-
moderate
• Avoid alcohol intake and other relaxation drugs
• Monitor fluid in put and out put chart
Drug Mgt of HF/CCF
• Diuretics=effective symptomatic relief in patients
with peripheral oedema or pulmonary oedema and
rapidly relieve dyspnoea.
• Frusemide/Lasix oral/IV/IM 20mg-80mg daily in
morning can be increased to 160mg in divided
doses prn (1mg/kg)
• Plus sprinolactone (Aldactone A) 25mg-50mg bd
(1.5mg-3mg/kg) if oedema persists
• Others include; Bendrofluazide/Aprinox 5mg-10mg
od in mild to moderate cases, Metolazone
combined with frusemide to enhance diuresis
Drug mgt HF/CCF cont’d
• Diuretics RX is not sufficient on its own as clinical
stability tends to deteriorate over time
• Beta blockers; reduce hospitalization, sudden death
and overall mortality in CHF and recommended in
RX of severe CHF.
• Tab carvedilol 3.125mg bd increased gradually
depending on response. Metoprolol
• Digoxin-Increases the strength of the heart’s
pumping action and is good patients with severe HF
esp due to certain disturbance of the heart rhythm
• It decreases relapses of HF& re-admissions
Drug Mgt of HF/CCF cont’d
• In urgent situations; digoxin injection loading dose
250mcg (0.25mg) IV 3-4times in the first 24 hours.
• Maintenance dose 250mcg (0.25mg) daily
• In non urgent situations; Tab loading dose 0.5mg-
1mg orally daily in 2-3 divided doses for 2-3days
• Maintenance dose 250mcg orally daily and elderly
patients 125mcg daily (15mcg/kg) daily for 5 days
• NOTE: Ensure patient has not been taking digoxin in
the past 14 days before digitalizing because of risk
of toxicity due to accumulation in the tissues.
• ACE inhibitors e.g Captopril, Enalapril, Lisinopril
Mgt of HF/CCF
• Tab Captopril 6.25mg tds, starting dose then
Maintenance dose of 50mg tds
• For acute pulmonary oedema (severe chest pain)
e.g Morphine 5-15mg (0.1mg/kg) repeated every 4-
6 hours until there is improvement.
HYPERTENSION=C.O X P.R
PRESENTATION OUTLINE
1. Definition
2. Risk factors/Causes
3. Classification of HTN
4. Types of HTN
5. Signs and symptoms
6. Investigations
7. Hypertensive emergency
8. Hypertensive crisis
9. Management
10.Complications
Definition
HTN is persistent elevation of blood pressure higher
than normal for a patient's age.
 The elevation may occur during systolic phase
(when the heart is in contractile phase) or during
the diastolic phase (when the heart is in relaxation
phase).
Generally a sustained BP of 140/90mmHg and
above indicate HTN.
HTN can also be defined as persistent high resting
blood pressure.
Causes
• Un known/idiopathic (majority of cases)-essential
HTN
Secondary causes
Chronic glomerulonephritis, Pyelonephritis
Eclampsia and preclampsia (pregnancy)
Renal failure Drugse.g oral
contraceptives&steroids
Cushing’s syndrome Coarctation of the aorta
Phaeochromocytoma Alcohol intoxication
Primary aldosteronism
Renal vascular diseases
Risk factors of HTN
Old age(>60 years)
DM
Hyperlipidemia
Obesity/over weight, High sodium intake
Smoking
Stress
Family history of CVS diz
Sedentary life style/lack of exercises
Execessive alcohol intake
See HF/CCF for more
Classification of BP/HTN
Systolic (mmHg) Diastolic (mmHg) Category
<130 <80 Normal
<90 <60 Hypotension
130-139 81-89 High normal (pre HTN)
140-159 90-99 Mild HTN (stage 1)
160-179 100-109 Moderate HTN (stage 2)
180-209 >110 Severe HTN (stage 3)
>209 Very severe HTN (stage 4)
Types of HTN
1. Essential HTN (primary HTN)
Most common and cause not known
Contributes to 90-95% of the cases of HTN in medical
practice.
2. Secondary HTN
Elevation of BP due to an identifiable cause e.g see
above. There is poor response to RX (resistant HTN),
worsening control in previously stable patients,
systolic BP of >180mmHg, or diastolic of >110mmHg,
no family H/O HTN, onset of HTN < 20 years,
significant hypertensive target organ damage.
Types of HTN cont’d
• Secondary HTN accounts for 5-10%
• Primary HTN affects both sexes equally ratio 1:1
• Primary HTN often seen in later years of life and
usually has familial history.
• If both parents were/are suffering from HTN, there
is 45% chances of their children suffering from HTN
• Severity of HTN increases gradually but can be
acute or progressive with a poor prognosis known
as malignant HTN
Signs and Symptoms of HTN
• There is no s/s specific to HTN instead it is
diagnosed by chance during routine medical
examinations. S/S include
• Headache Anxiety
• Palpitations Nervousness
• Breathlessness/DIB
• Dizziness Weight loss
• Chest pain Insomnia
• Epistaxis Irritability
• Wheezing
Complications of HTN
• Some patients may present with symptoms
associated with complications
The include;
Stroke (Brain)
Renal failure (Kidney)=oliguria
Impaired vision/blurred vision (Eyes)
Heart failure (Heart)=oedema, DIB, Orthpnoea
Heart attack
Hypertensive encephalopathy=fits/convulsions,
vertigo, impaired memory and concentration
Investigations
FBC/CBC
Chest X-ray
Fasting blood sugar (FBS)
Urinalysis
ECG/ECHO
RFTs
Serum uric acid
Total, high and low density lipoprotein cholesterol
Management of HTN
Aim of Rx
To normalize BP to less than 140/90mmHg
To avoid hypotension and to improve survival
To avoid adverse drug effects
To prevent or retard end-organ damage
Supportive Mgt
Sodium restriction (reduce salt intake)
Weight reduction if patient is obese
Regular aerobic exercises (little jogging)
Behavioral modification to reduce stress
Supportive MGT cont’d
Restriction of alcohol
Avoidance of smoking
Increased consumption of fruits and vegetables
Re-evaluate patients after4-6weeks and if still
hypertensive, then drug RX is recommended
Patient education is important as non compliance is
a major cause of poor response to RX
Appropriate counseling and patient follow up is
needed to understand the risk of untreated HTN.
This mgt is for mild HTN
Drug mgt=moderate-severe HTN
• Drug combination is important in mgt of HTN
1. Angiotensin enzyme converting inhibitors (ACEI)
e.g captopril 25-50mgtds, Lisinopril 5mg, Enalapril
2. Beta blockers e.g Carvedilol, Atenolol, propranolol
3. Calcium channel blockers e.g Nifedipine,
Amlodipine, Felodipine
4. Diuretics e.g Bendrofluazide, Furosemide,
Sprinolactone
5. Angiotensin-II antagonist e.g Losartan and
Valsartan
6. Centrally-acting anti-HTN e.g Methylodopa
Drug mgt cont’d
• Tab Atenolol 50-100mg od/bd prn
• Tab Propranolol 40mg-120mg bd/tds
• Tab Carvedilol 3.125mg-6.25mg od/bd
• Tab Furosemide 40mg-80mg od in morning
(1mg/kg)
• Tab Sprinolactone (Aldactone A) 25mg-50mg od/bd
• Tab Bendrofluazide 2.5mg-5mg od morning
• Tab Nifedipine 20mg-40 bd/tds
• Tab Amlodipine 5mg-10mg bd
• Tab Losartan 50mg od/bd
• Methylodopa 250mg bd/tds
Drug mgt cont’d
• AB/CD/BC/ABC/BCD can be used
• Propranolol, atenolol should not use in heart failure
and asthma
• Diuretics should not use in pregnancy or breast
feeding except in case of pulmonary oedema or pre-
eclampsia.
• Make notes about suitability safety of ant
hypertensive in different conditions like
DM,CCF,COPD/Asthma, Ischaemic heart diseases,
Chronic renal failure etc
Hypertensive crisis
• This is a group of acute hypertensive disorders
characterized by end organ damage
(180/120mmHg).
• In hypertensive crisis, arterial BP rises rapidly and
severely, threatening the patient's life and can
quickly comprises the patient's cerebral,
cardiovascular and renal function.
• Non compliance and rebound HTN following
withdrawal of RX should always be considered as an
etiological factor.
Classification of Hypertensive crisis
• Hypertensive urgency and emergency
Hypertensive urgency
• This is a clinical situation in which there is an
elevation of blood pressure but end organ damage
is less acutely progressive (gradual).
• Hypertensive urgency is less life threatening.
Signs and symptoms
• Severe headache
• Nausea and vomiting
• Dyspnoea
• Blurred vision
• Chest pain, leg & arm numbness &tingling
• Progressive impairment of consciousness
Mgt of hypertensive urgency
• Nifedipine, Captopril and Prazosin
Hypertensive emergency
This is a clinical situation in which there is an
elevation of BP complicated by life threatening end
organ damage (acute).
Situations in which HTN is considered an emergency
are;
Hypertensive encephalopathy
Acute aortic dissection Stroke
Pulmonary oedema Acute MI, unstable angina
Pre-eclampsia and Eclampsia
Mgt of hypertensive emergency
• It requires rapid (within one hour) lowering of BP to
prevent any organ damage.
• Admit a patient
• IV furosemide 40-80mg stat
• Iv hydralazine 20mg slowly in D5% over 20minutes
• Check BP regulary at least 3 hourly
• Rapidly acting antihypertensive e.g sodium
nitroprusside, hyralazine (Apresoline) and Labetalol
are normally used.
ISCHEAMIC HEART DISEASES (IHD)
1. Angina pectoris
2. Acute myocardial infarction
NOTE: IHD can also be called Coronary heart disease
(CHD)
ANGINA PECTORIS
This is a syndrome characterized by discomfort that
occurs when the myocardial oxygen demand
exceeds supply.
A clinical syndrome as result of coronary blood flow
being less than required hence lack of 02 in heart
muscle. Transient myocardial ischemia
Signs and symptoms
Chest pain Dizziness
Nausea Shortness of breath
Left arm discomfort Sweating
S/S cont’d
Chest tightness in the middle of the chest like a
band around chest. Sense of oppression worsening
on exertion, relieved by rest and lasting for a few
minutes.
Pain radiates to left hand and neck& is more
induced after meals and cold weather.
Pain is also induced by exercise and relieved by rest
Pain is likely to be worse when walking against wind
or uphill/cold weather/after meals
Some patients are wakened up by pain(nocturnal
angina) with alarming dreams
S/S cont’d
Some patients experience pain when lying flat
(angina decubitus)
Pulse is weak and irregular, lasts for several hours
Patient may go into shock, Dyspnoea
Anxiety sweating, vomiting
Low BP
Arrhythmias
Differential diagnosis
Indigestion
Peptic ulcer disease
Pleurisy
Pericarditis
Severe anaemia
Dissecting aneurysm (Separation of layers of
aorta plus dilatation)
Risk factors of Angina
Advanced age
DM
Oral contraceptives
Gender (males are more prone)
HTN (especially when systolic BP>180mmHg)
Calcium channel blockers e.g amlodipine
Obesity
Smoking
Hyperlipidemia
Hypothyroidism
Classification of Angina
Stable angina
Unstable angina
Prinzmetal’s angina
Stable angina (Chronic stable angina)
Usually precipitated by exertion and relieved by rest
Frequency, intensity & duration of attack are stable
Usually followed by precipitating factors e.g
Climbing stairs A heavy meal
Sexual intercourse Cold weather
Emotional stress
• Caused by a fixed coronary obstruction secondary
to atherosclerosis.
Unstable angina (coronary syndrome)
Unstable angina is a clinical syndrome intermediate
between stable angina and acute myocardial
infarction. Characterized by
Recent onset
Increasing severity, duration or frequency of attacks
It occurs at rest or with minimal exertion
It may be due to plaque rupture
Prinzmetal’s angina
Occurs spontaneously when the patient is at rest
with greater frequency during the night or early
hours in the morning.
It carries considerable risk of progression to
myocardial infarction.
It is caused by coronary artery spasm with or
without significant coronary artery disease.
Patients are also more likely to develop ventricular
arrhythmias.
It is common in women over 30 years .
Supportive mgt
Weight reduction in obese patients
Regular aerobic exercises
Correction of folate deficiency
Low cholesterol/low fat and low sodium intake
Advise the patient to stop smoking
Correction of possible aggravating factors e.g
anemia, HTN, DM, hyperlipideamia etc
Monitor closely pulse rate and circulatory status
Effective control of HTN and DM
Drug mgt
Nitrates e.g Sublingual nitroglycerine and isosorbide
dinitrate
Glyceryl trinitrate 500mcg sublingually, repeat after
5min if no response
Beta blockers e.g atenolol, propranolol 10-40mg prn
Avoid it patinets with shock or hypotension
Calcium channel blockers e.g nifedipine, amlodipine
Acetylsalicyclic acid 150mg single dose 2 be chewed
MYOCARDIAL INFARCTION (MI)
1. Definition
2. Cause
3. Risk factors
4. Signs and symptoms
5. Investigations
6. Management
Definition
This is necrosis of heart muscles resulting from an
insufficient supply of oxygenated blood to an area
of the heart.
It results from occlusion of a coronary artery by a
thrombus supplying that area.
OR it is a condition in which part of myocardium is
damaged due to a major obstruction in the
coronary artery that part of the heart gets
insufficient blood supply and dies off.
The infarct may affect full thickness of the
myocardium or it may be confined to sub
endocardial region.
Aetiology/cause
Coronary thrombosis is the main cause due to
arteriosclerosis.
It always due to formation of an occlusive thrombus
at any site in the coronary artery.
 The thrombus often undergoes spontaneous lysis
over the next 2days although at this time
myocardial damage has already occurred.
Risk factors of MI
Cigarette smoking
Obesity
DM
Family history of heart disease
HTN
Excessive alcohol intake
Previous cardiovascular disease e.g angina pectoris
Plasma lipid abnormalities/high cholesterol levels
Old age
Signs and symptoms of MI
Weakness/fainting/extreme fatigue
Bradycardia
Sweating
Severe tight chest pain lasting more than 20minutes
Patient usually restless and in severe pain
Low BP (hypotension)
Bilateral crackle in the chest
Shortness of breath/dyspnoea
Feeling of indigestion
Nausea and vomiting
S/S cont’d
Pain is more described as tightness or heaviness or
constriction in the chest
At its worst, pain is one of the most severe pain to
be experienced by a patient in which pallor may
convey the seriousness of the situation.
Cyanosis may occur
Vomiting and sinus Bradycardia may be due to
vagus nerve stimulation but vomiting can also be
aggravated by opiate analgesics.
Patient may have fever and die off in a few days.
Investigations
ECG/ECHO
Fasting blood sugar
FBC/CBC
Serum lipid profile
Cardiac enzymes
Blood urea and creatinine (RFTs)
DDX
Angina pectoris
Pericarditis
Mitral valve stenosis
Complications of MI
Heart failure due of impaired contraction of the
myocardium
Rupture of the heart
Severe arrhythmias
Pulmonary embolism
Pulmonary infarction
Pericarditis
Management of MI
Aims of mgt
To abort infarction
To increase myocardial oxygen delivery
To provide symptomatic relief of pain and reduce
anxiety
To prevent complications and recurrences
To reduce mortality and improve the quality of life
To rehabilitate the patient and also prevent
arrhythmias
Mgt of acute attack of MI
Morphine IV 5mg-10mg to relieve pain and anxiety
Oxygen therapy to all patients except those with
COPD
Nitrates e.g Glyceryl trinitrate 500mcg sublingually,
repeated after 5min if no response to relieve
Ischaemic pain
Aspirin 75mg-150mg (cardiac aspirin/Ecorin 75mg)
to dissolve the clots or other antiplatelets
Metoclopramide 5-10mg IV/IM may be added to
prevent nausea and vomiting associated with
morphine
Always remember MONA in AMI
Long term mgt of MI
Supportive mgt
Control of HTN
Rest and reassurance
Avoid smoking
Exercises regularly should be mild during the period
when infarct is replaced by a fibrous tissue 4-6wks
Reduce weight for obese patients
Proper control of DM
Avoid sedentary lifestyles
Eating vegetables and fruits
Avoid fatty diet
Long term drug mgt of MI
Aspirin 75mg-150mg daily (prolonged use) by
mouth to reduce the rate of reinfarction
Beta blockers e.g atenolol 5mg-10mg or
propranolol should be continued for at least one
year (for arrhythmias)
Nitrates may be required for patients with angina
Statins e.g simvastatin may be used in patients with
high risk of reoccurrence
Thrombolytic drugs e.g IV streptokinase 1.5mu in
100mls of N/S as an infusion over 1 hour is useful in
acute attacks.
STROKE (CVA)
PRESENTATION OUTLINE
1. Definition
2. Classification
3. Causes
4. Risk factors
5. Symptoms and signs
6. Investigations
7. Management
Definition and classification of stroke
This is acute brain injury caused by decreased blood
supply or heamorrhage.
Stroke is a medical emergency and can cause
permanent neurological damage, complications and
death if not promptly DX and RX.
Classification of stroke
1. Ischaemic stroke (lack of blood supply caused by
thrombosis or embolism)
2. Haemorrhagic stroke
Causes of stroke
Blood clot (embolism from distant site)
Cardio-embolic stroke accounting for 20-25% of all
stroke
Cerebral heamorrhage (secondary to HTN)
Clotting with in the artery (Thrombosis)
Risk factors of stroke
Hypertension
Cigarette smoking
Excessive alcohol intake
Undesirable blood cholesterol (LDL/HDL)
DM
Obesity
Old age
Signs and symptoms of stroke
Sudden onset of weakness or numbness of the face,
arm or leg
Sudden lack of coordination of the limbs
Sudden vision loss or double vision
Sudden difficult in speaking
Severe dizziness
Loss of balance
Severe headache
Paraplegia/hemiplegia/monoplegia
Coma
Muscle weakness/paresis
Investigations
Fasting blood sugar
Urinalysis
FBC/CBC
Serum triglycerides and cholesterol (lipid profile)
Chest/skull x-ray
ECG and ECHO
CT scaninng
Management of stroke
Supportive mgt
Admit the patient if unable to walk
Ensure adequate oxygenation
Ensure adequate fluid and electrolyte balance
Prevent pressure sores by regular turning of the
patient, Pass Nasogastric tube for feeding
Pass urethral catheter to keep patient clean
Physiotherapy should be started as soon as BP
stabilizes
Prophylactic anticoagulants to prevent
thromboembolism
Drug mgt
Acute stroke (Ischaemic/haemorrhagic)
Antiplatelet Rx e.g Aspirin 150mg-300mg started
with in 48hours of the onset of Ischaemic stroke
IV Clexane 40iu od/bd
Anticoagulants e.g Heparin
Anticoagulants and antiplatelets drugs are not used
in the mgt of hemorrhagic stroke as they may
exacerbate bleeding
The main treatment in this type of stroke is to
normalize HTN
Long term mgt of stroke
Adequate control of HTN, DM,
Hyperlipidemia e.g artovastastin tab 10mg increase
after 4weeks max 40mg/day, simvastatin
Reduction of alcohol consumption
Advise the patient to stop smoking
Tab Aspirin 75mg-150mg daily prn
Tab Dipyridamole 300mg-600mg in 3-4 divided
doses OR
Tab Clopidogrel initially 300mg then 75mg od
CARDIOVASCULAR CONDITIONS-1.ppt
CARDIOVASCULAR CONDITIONS-1.ppt

More Related Content

Similar to CARDIOVASCULAR CONDITIONS-1.ppt

CCF- B.M.pptx
CCF- B.M.pptxCCF- B.M.pptx
CCF- B.M.pptx
EvansMwenya2
 
Cardiovascular diseases & Dental Management
Cardiovascular diseases & Dental ManagementCardiovascular diseases & Dental Management
Cardiovascular diseases & Dental Management
Dr.Priyanka Sharma
 
05 Shaikha Al Faresi
05 Shaikha Al Faresi05 Shaikha Al Faresi
05 Shaikha Al Faresi
drmohamedali
 
Cardiac Function Tests.ppt
Cardiac Function Tests.pptCardiac Function Tests.ppt
Cardiac Function Tests.ppt
KashifBashir51
 
Approach to patient with cardiovascular disease.pptx
Approach to patient with cardiovascular disease.pptxApproach to patient with cardiovascular disease.pptx
Approach to patient with cardiovascular disease.pptx
tesa10
 
Heart failure
Heart failureHeart failure
Heart failure
Chandrani Goswami
 
MED Cvs
MED CvsMED Cvs
MED Cvs
O J
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
faculty of nursing Tanta University
 
Valvular heart disease.pdf
Valvular heart disease.pdfValvular heart disease.pdf
Valvular heart disease.pdf
DrAliAlsaady1
 
Pulmonary vascular Disease
Pulmonary vascular DiseasePulmonary vascular Disease
Pulmonary vascular Disease
Euvette Taylor
 
Valvular heart disease
Valvular heart diseaseValvular heart disease
Valvular heart disease
Ratheeshkrishnakripa
 
valvularheart-161006101806 (1).pdf
valvularheart-161006101806 (1).pdfvalvularheart-161006101806 (1).pdf
valvularheart-161006101806 (1).pdf
jiregnaetichadako
 
Congestive right heart failure
Congestive right heart failureCongestive right heart failure
Congestive right heart failure
paras suthar
 
Congestive Heart Failure a killer disease.ppt
Congestive Heart Failure a killer disease.pptCongestive Heart Failure a killer disease.ppt
Congestive Heart Failure a killer disease.ppt
azkashaf871
 
Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...
Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...
Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...
birukberg11
 
Cardiac Failure Sem 5.pptx
Cardiac Failure Sem 5.pptxCardiac Failure Sem 5.pptx
Cardiac Failure Sem 5.pptx
Sharveen2
 
Acyanotic heart disease
Acyanotic heart diseaseAcyanotic heart disease
Acyanotic heart disease
Balasingam Balagobi
 
2CVS ppt. FETAL CIRCULATION & CCF.ppt
2CVS ppt.  FETAL CIRCULATION & CCF.ppt2CVS ppt.  FETAL CIRCULATION & CCF.ppt
2CVS ppt. FETAL CIRCULATION & CCF.ppt
MaryannNyambura
 
Symptoms Signs & Investigations in Cardiovascular Diseases
Symptoms Signs & Investigations in Cardiovascular DiseasesSymptoms Signs & Investigations in Cardiovascular Diseases
Symptoms Signs & Investigations in Cardiovascular Diseases
drnooruddin
 
Symptoms Signs Investigations in Cardiovascular Diseases
Symptoms Signs Investigations in Cardiovascular DiseasesSymptoms Signs Investigations in Cardiovascular Diseases
Symptoms Signs Investigations in Cardiovascular Diseases
drnooruddin
 

Similar to CARDIOVASCULAR CONDITIONS-1.ppt (20)

CCF- B.M.pptx
CCF- B.M.pptxCCF- B.M.pptx
CCF- B.M.pptx
 
Cardiovascular diseases & Dental Management
Cardiovascular diseases & Dental ManagementCardiovascular diseases & Dental Management
Cardiovascular diseases & Dental Management
 
05 Shaikha Al Faresi
05 Shaikha Al Faresi05 Shaikha Al Faresi
05 Shaikha Al Faresi
 
Cardiac Function Tests.ppt
Cardiac Function Tests.pptCardiac Function Tests.ppt
Cardiac Function Tests.ppt
 
Approach to patient with cardiovascular disease.pptx
Approach to patient with cardiovascular disease.pptxApproach to patient with cardiovascular disease.pptx
Approach to patient with cardiovascular disease.pptx
 
Heart failure
Heart failureHeart failure
Heart failure
 
MED Cvs
MED CvsMED Cvs
MED Cvs
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Valvular heart disease.pdf
Valvular heart disease.pdfValvular heart disease.pdf
Valvular heart disease.pdf
 
Pulmonary vascular Disease
Pulmonary vascular DiseasePulmonary vascular Disease
Pulmonary vascular Disease
 
Valvular heart disease
Valvular heart diseaseValvular heart disease
Valvular heart disease
 
valvularheart-161006101806 (1).pdf
valvularheart-161006101806 (1).pdfvalvularheart-161006101806 (1).pdf
valvularheart-161006101806 (1).pdf
 
Congestive right heart failure
Congestive right heart failureCongestive right heart failure
Congestive right heart failure
 
Congestive Heart Failure a killer disease.ppt
Congestive Heart Failure a killer disease.pptCongestive Heart Failure a killer disease.ppt
Congestive Heart Failure a killer disease.ppt
 
Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...
Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...
Birukfgffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff...
 
Cardiac Failure Sem 5.pptx
Cardiac Failure Sem 5.pptxCardiac Failure Sem 5.pptx
Cardiac Failure Sem 5.pptx
 
Acyanotic heart disease
Acyanotic heart diseaseAcyanotic heart disease
Acyanotic heart disease
 
2CVS ppt. FETAL CIRCULATION & CCF.ppt
2CVS ppt.  FETAL CIRCULATION & CCF.ppt2CVS ppt.  FETAL CIRCULATION & CCF.ppt
2CVS ppt. FETAL CIRCULATION & CCF.ppt
 
Symptoms Signs & Investigations in Cardiovascular Diseases
Symptoms Signs & Investigations in Cardiovascular DiseasesSymptoms Signs & Investigations in Cardiovascular Diseases
Symptoms Signs & Investigations in Cardiovascular Diseases
 
Symptoms Signs Investigations in Cardiovascular Diseases
Symptoms Signs Investigations in Cardiovascular DiseasesSymptoms Signs Investigations in Cardiovascular Diseases
Symptoms Signs Investigations in Cardiovascular Diseases
 

More from AbwoneKenneth

chemotherapy lecture notes.1.ppt
chemotherapy lecture notes.1.pptchemotherapy lecture notes.1.ppt
chemotherapy lecture notes.1.ppt
AbwoneKenneth
 
MACROLIDES AND CLINDAMYCIN.ppt
MACROLIDES AND CLINDAMYCIN.pptMACROLIDES AND CLINDAMYCIN.ppt
MACROLIDES AND CLINDAMYCIN.ppt
AbwoneKenneth
 
5. Introduction and background.ppt
5. Introduction and background.ppt5. Introduction and background.ppt
5. Introduction and background.ppt
AbwoneKenneth
 
9. Counselling.ppt
9. Counselling.ppt9. Counselling.ppt
9. Counselling.ppt
AbwoneKenneth
 
Antibiotics Lecture-1-Penicillins.ppt
Antibiotics Lecture-1-Penicillins.pptAntibiotics Lecture-1-Penicillins.ppt
Antibiotics Lecture-1-Penicillins.ppt
AbwoneKenneth
 
IDI_pharmacology_of_antifungal[1] new.ppt
IDI_pharmacology_of_antifungal[1] new.pptIDI_pharmacology_of_antifungal[1] new.ppt
IDI_pharmacology_of_antifungal[1] new.ppt
AbwoneKenneth
 
9 Volatile Oil.ppt
9 Volatile Oil.ppt9 Volatile Oil.ppt
9 Volatile Oil.ppt
AbwoneKenneth
 
Leaves2.ppt
Leaves2.pptLeaves2.ppt
Leaves2.ppt
AbwoneKenneth
 
Good medical stores management-1.ppt
Good medical stores management-1.pptGood medical stores management-1.ppt
Good medical stores management-1.ppt
AbwoneKenneth
 
diterpenoid.ppt
diterpenoid.pptditerpenoid.ppt
diterpenoid.ppt
AbwoneKenneth
 
AUTACOIDS-1.ppt
AUTACOIDS-1.pptAUTACOIDS-1.ppt
AUTACOIDS-1.ppt
AbwoneKenneth
 
DRUGS FOR PUD2.ppt
DRUGS FOR PUD2.pptDRUGS FOR PUD2.ppt
DRUGS FOR PUD2.ppt
AbwoneKenneth
 
GIT DRUGS-1-1.ppt
GIT DRUGS-1-1.pptGIT DRUGS-1-1.ppt
GIT DRUGS-1-1.ppt
AbwoneKenneth
 
6.STERILIZATION BY FILTRATION.ppt
6.STERILIZATION BY FILTRATION.ppt6.STERILIZATION BY FILTRATION.ppt
6.STERILIZATION BY FILTRATION.ppt
AbwoneKenneth
 
4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt
AbwoneKenneth
 
Meeting-1.ppt
Meeting-1.pptMeeting-1.ppt
Meeting-1.ppt
AbwoneKenneth
 
Medical Ethics-2.ppt
Medical Ethics-2.pptMedical Ethics-2.ppt
Medical Ethics-2.ppt
AbwoneKenneth
 
12 Gums and Mucilage.ppt
12 Gums and Mucilage.ppt12 Gums and Mucilage.ppt
12 Gums and Mucilage.ppt
AbwoneKenneth
 
ANTIVIRAL DRUGS.ppt
ANTIVIRAL DRUGS.pptANTIVIRAL DRUGS.ppt
ANTIVIRAL DRUGS.ppt
AbwoneKenneth
 
3.STERILIZATION..-1.ppt
3.STERILIZATION..-1.ppt3.STERILIZATION..-1.ppt
3.STERILIZATION..-1.ppt
AbwoneKenneth
 

More from AbwoneKenneth (20)

chemotherapy lecture notes.1.ppt
chemotherapy lecture notes.1.pptchemotherapy lecture notes.1.ppt
chemotherapy lecture notes.1.ppt
 
MACROLIDES AND CLINDAMYCIN.ppt
MACROLIDES AND CLINDAMYCIN.pptMACROLIDES AND CLINDAMYCIN.ppt
MACROLIDES AND CLINDAMYCIN.ppt
 
5. Introduction and background.ppt
5. Introduction and background.ppt5. Introduction and background.ppt
5. Introduction and background.ppt
 
9. Counselling.ppt
9. Counselling.ppt9. Counselling.ppt
9. Counselling.ppt
 
Antibiotics Lecture-1-Penicillins.ppt
Antibiotics Lecture-1-Penicillins.pptAntibiotics Lecture-1-Penicillins.ppt
Antibiotics Lecture-1-Penicillins.ppt
 
IDI_pharmacology_of_antifungal[1] new.ppt
IDI_pharmacology_of_antifungal[1] new.pptIDI_pharmacology_of_antifungal[1] new.ppt
IDI_pharmacology_of_antifungal[1] new.ppt
 
9 Volatile Oil.ppt
9 Volatile Oil.ppt9 Volatile Oil.ppt
9 Volatile Oil.ppt
 
Leaves2.ppt
Leaves2.pptLeaves2.ppt
Leaves2.ppt
 
Good medical stores management-1.ppt
Good medical stores management-1.pptGood medical stores management-1.ppt
Good medical stores management-1.ppt
 
diterpenoid.ppt
diterpenoid.pptditerpenoid.ppt
diterpenoid.ppt
 
AUTACOIDS-1.ppt
AUTACOIDS-1.pptAUTACOIDS-1.ppt
AUTACOIDS-1.ppt
 
DRUGS FOR PUD2.ppt
DRUGS FOR PUD2.pptDRUGS FOR PUD2.ppt
DRUGS FOR PUD2.ppt
 
GIT DRUGS-1-1.ppt
GIT DRUGS-1-1.pptGIT DRUGS-1-1.ppt
GIT DRUGS-1-1.ppt
 
6.STERILIZATION BY FILTRATION.ppt
6.STERILIZATION BY FILTRATION.ppt6.STERILIZATION BY FILTRATION.ppt
6.STERILIZATION BY FILTRATION.ppt
 
4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt
 
Meeting-1.ppt
Meeting-1.pptMeeting-1.ppt
Meeting-1.ppt
 
Medical Ethics-2.ppt
Medical Ethics-2.pptMedical Ethics-2.ppt
Medical Ethics-2.ppt
 
12 Gums and Mucilage.ppt
12 Gums and Mucilage.ppt12 Gums and Mucilage.ppt
12 Gums and Mucilage.ppt
 
ANTIVIRAL DRUGS.ppt
ANTIVIRAL DRUGS.pptANTIVIRAL DRUGS.ppt
ANTIVIRAL DRUGS.ppt
 
3.STERILIZATION..-1.ppt
3.STERILIZATION..-1.ppt3.STERILIZATION..-1.ppt
3.STERILIZATION..-1.ppt
 

Recently uploaded

Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 

Recently uploaded (20)

Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 

CARDIOVASCULAR CONDITIONS-1.ppt

  • 1. CARDIOVASCULAR CONDITIONS/DISEASES COURSE OUTLINE 1. Hypertension 2. Heart failure/Congestive cardiac failure 3. Ischaemic heart diseases 4. Pericarditis Deep venous thrombosis (DVT) 5. Myocarditis Rheumatic heart disease 6. Endocarditis Alcoholic heart disease 7. Cardiomyopathies 8. Congenital abnormalities Aortic aneurysm 9. Pulmonary oedema Nutritional H Disease 10. Pulmonary embolism
  • 2. General Signs and Symptoms of CVS D/Os 1. Dyspnoea-Its awareness of breathlessness on exertion which is frequently the first symptom of HF. It is hard to distinguish from dyspnoea due to lung d’se. • Patients with HF take rapid shallow breath, wheezes but excessive use of muscles of respiration is uncommon. 2. Cough-Repeatitive unproductive cough in the presence of pulmonary oedema is an important symptom in left sided heart failure. 3. Wheezing-when it becomes prominent its called cardiac asthma.
  • 3. General Signs and Symptoms cont’d 4. Orthopnoea-its dyspnoea that occurs when a patient is lying down flat and improves upon sitting up or breathlessness which prevents a patient from lying flat. • Lying down rises the right atrial pressure and the right ventricular out put forcing more blood into lungs. Breathlessness is due to stiffness of the congested lungs & partly due to direct stimulation of the fine nerve endings around the alveoli. • Orthopnoea suggest left ventricular failure or mitral valve stenosis but may also accompany COPD
  • 4. S/S CONT’D 5. Paroxysmal nocturnal dyspnoea-episodes of sudden dyspnoea and orthopnoea that wakes up a patient from sleep, usually 1-2 hours after going to sleep. The patient has to sit up for relieve & may be associated with wheezing and cough. • It suggests Left ventricular HF or mitral valve stenosis & may mimic nocturnal asthmatic attacks 6. Chynestokes respiration(periodic breathing) • Common in severe HF but can also occur in elderly patients without any evidence of HF particularly during sleep.
  • 5. S/S CONT’D 7. Peripheral Oedema (pedal/ankle/tibial oedema) • Accumulation of fluids in tissues/interstsial spaces • Occurs in HF due to excessive salts & water retention. Found mainly in the feet & ankles in ambulant patients as this site is largely determined by gravity. Pressure with a thumb if sustained will displace the fluid leaving a pit hence it is referred as bilateral, non tender pitting pedal oedema • In severe HF fluid may accumulate in pleural and abdominal cavity causing pleural effusion and ascites respectively
  • 6. S/S CONT’D 8. Chest pain-cardinal symptom of Ischaemic heart diseases e.g Angina pectoris& myocardial infarction The stabbing squeezing tight chest pain felt momentarily at cardiac apex is referred to as Precordial catch. It is often indicated by a finger pointing below the left apex beat. Chest pain can also signify lung or muscular system problem 9. Pleural pain- feature/symptom of pulmonary infarction which often complicates HF
  • 7. S/S CONT’D 11. Hepatic Pain- Felt in the right epigastrium and some times a sign of acute or worsening HF. It is due to hepatic distension from rise in central venous pressure. It can be due to straining of the liver capsule Coz of blood accumulation in liver RHF. 12. Palpitations-awareness of heart beat as a result of exercise or anxiety. Occurs due to increased catecholamine secretion (adrenaline and noradrenaline) and sympathomimetic drugs. 13. Others s/s include; Easy fatigability, Exercise intolerance
  • 8. Classification of Heart conditions 1. Disorders of heart rate and rhythm e.g Tachycardia and Bradycardia 2. Ischaemic heart diseases e.g angina pectoris & MI 3. Valvlar heart diseases e.g Rheumatic heart disease, Infective endocarditis (sub acute bacterial endocarditis) 4. Vascular heart diseases e.g HTN, peripheral arterial diz like arteritis, aortic lessions, thromboembolism etc 5. Diseases of the myocardium e.g myocarditis, cardiomyopathies (dilated/restrictive), EMF
  • 9. Classification cont’d 6. Congenital heart defects e.g • Patent ductus arteriosus (failure of ductus to close at birth)= Ductus arteriosus shunt/communication btn P.A & Aorta during foetal circulation/uterus • Atrial septal defect=communication btn atria (R/L) • Ventricular septal defect=communication btn ventricles (R/L) • Coarcitation of the aorta=narrowing of the aorta usually just distal to the origin where D.A inserts. 7. Diseases of the blood vessels e.g atherosclerosis, arteritis, phlebitis
  • 10. Classification cont’d 8. Pericardial diseases e.g Pericarditis, Pericardial effusion, constrictive pericarditis 9. Syphilitic heart diseases 10. Heart diseases secondary to lung disease e.g cor- pulmonale Cheynestoke respiration= Breathing commencing with shallow & slow respn which decreases in rate & depth & ceases for 10 seconds before commencing (periodic breathing)
  • 11. Effects of CVS Diz of body fxns Diseases of the heart causes its inability to produce an out put sufficient to meet patients’ needs. This affects the body functions causing a number of manifestations. CVS e.g Pallor of mucus membranes, cyanosis, tachycardia and chest pain RS e.g cough, dyspnoea, pulmonary congestion, haemoptysis
  • 12. Effects of CVS CONT’D NS e.g Insomnia, amnesia, mental changes & delusions, delirium GIT e.g Anorexia, dyspepsia, flatulence, constipation, liver congestion Urinary system e.g diminished urine output, albuminuria General e.g Oedema, Ascites and Pleural effusion
  • 13. CARDIAC FAILURE/HEART FAILURE By Frank.s PRESENTATION OUTLINE 1. Definition 2. Risk factors 3. Types of HF 4. Sign and symptoms 5. Complications 6. Investigations 7. Differentials 8. Management
  • 14. Definitions of HF 1. It’s a condition in which an abnormality of myocardial fxn is responsible for the inability of the ventricles to deliver adequate quantities of blood to metabolizing tissues at rest or during normal activity. It describes a state when the heart cant maintain adequate cardiac out put and it does so at high filling pressures. 2. CCF is a condition where the heart muscle becomes weak and is unable to pump sufficient oxygenated blood to meet the metabolic needs of the tissues.
  • 15. Definitions cont’d 3. Inadequate cardiac output for the body’s needs despite adequate venous return-may be due to failure of the left or right ventricles. Types of HF 1. Right sided HF= results in a back flow of blood in the venous circulation producing liver enlargement and oedema in the extremities. 2. Left sided HF= results in a back flow of blood in the pulmonary circulation, producing pulmonary oedema 3. Biventricular HF/CCF= Affects both sides/long term
  • 16. Types of HF cont’d • When RV fails to perform properly, the RA becomes distended leading to stasis in the venous system. • The pressure in the superior and inferior venacava rises. • The veins in the neck becomes distended (raised jugular venous pressure-JVP) • The liver becomes engorged and legs become oedematous, this is known as CCF.
  • 17. Causes of HF/CCF • Coronary heart diseases • Valvular heart diseases e.g rheumatic heart diz • Cardiomyopathies • Severe anaemia Myocardial infarction • Systemic HTN Chronic respiratory diz • Cardio toxicity arising from alcoholism • Unknown/idiopathic Congenital heart defects • Hyperthyroidism • Aortic stenosis • Post viral infections
  • 18. Risk factors of HF/CCF • Old age • Family history/predisposition • Lack of regular physical exercises • Obesity/over weight • High fat/high salt intake • Sedentary life style • Drugs like Aminophylline • Liver failure and Kidney failure • Pregnancy, Excessive Alcohol, Smoking • Abnormal pulse rhythm (Arthymias)
  • 19. Signs and symptoms of HF • Palpitations, cough , weakness • Rapid pulse, gallop rhythm • Dependent oedema/swelling in the ankles • Raised jugular venous pressure (JVP) • Enlarged tender liver (right abdominal pain due to stretching of liver capsule) • Orthopnea, paroxysmal nocturnal DIB, tachycardia • Exertional dyspnoea, fatigue, periodic breathing • Basal crepitations • Breathlessness & progressively decrease in effort tolerance Cardiac cachexia-Excessive wasting
  • 20. Complications of HF • Cerebral symptoms e.g confusion, difficult in concentration, impaired memory and headache • Oliguria i.e diminished urine out put due to renal failure • GIT symptoms e.g dyspepsia, nausea, heart burn, vomiting, anorexia due to congestion of the stomach and intestines • Respiratory failure with marked haemoptysis due to pulmonary infarcts in the lungs as a result of pulmonary congestion • Ascites and pleural effusion
  • 21. Differential diagnosis • Severe anaemia • Protein energy malnutrition (PEM) • Nephrotic syndrome • Asthma Renal failure, Liver failure/cirrhosis • Severe pneumonia/Pulmonary diseases Investigations • Chest x-ray to rule out cardiomegaly/P.Oedema/LVF • Blood for CBC/FBC, TPHA/RPR for syphilis • Echocardiogram and ECG • Lipid profile (LDL/HDL/Triglycerides) • RFTs (Urea/creatinine/electrolytes), LFTs
  • 22. Management of HF/CCF Aims of mgt/Principles of mgt 1. To relieve symptoms 2. To improve exercise tolerance 3. To reduce incidences of acute exacerbations 4. To reduce hospitalization and mortality 5. To eradicate risk/precipitating factors e.g anaemia 6. Reduction of the work load imposed on the heart by reducing obesity and having bed rest 7. Reduce salt intake and water retention
  • 23. Supportive Mgt • Bed rest with the head of the bed elevated when symptoms are severe • Prop up patient in sitting up position/cardiac bed • Reduce weight in obese patients • Limit salt/sodium intake • Stop smoking • Moderate physical exercises when s/s are mild- moderate • Avoid alcohol intake and other relaxation drugs • Monitor fluid in put and out put chart
  • 24. Drug Mgt of HF/CCF • Diuretics=effective symptomatic relief in patients with peripheral oedema or pulmonary oedema and rapidly relieve dyspnoea. • Frusemide/Lasix oral/IV/IM 20mg-80mg daily in morning can be increased to 160mg in divided doses prn (1mg/kg) • Plus sprinolactone (Aldactone A) 25mg-50mg bd (1.5mg-3mg/kg) if oedema persists • Others include; Bendrofluazide/Aprinox 5mg-10mg od in mild to moderate cases, Metolazone combined with frusemide to enhance diuresis
  • 25. Drug mgt HF/CCF cont’d • Diuretics RX is not sufficient on its own as clinical stability tends to deteriorate over time • Beta blockers; reduce hospitalization, sudden death and overall mortality in CHF and recommended in RX of severe CHF. • Tab carvedilol 3.125mg bd increased gradually depending on response. Metoprolol • Digoxin-Increases the strength of the heart’s pumping action and is good patients with severe HF esp due to certain disturbance of the heart rhythm • It decreases relapses of HF& re-admissions
  • 26. Drug Mgt of HF/CCF cont’d • In urgent situations; digoxin injection loading dose 250mcg (0.25mg) IV 3-4times in the first 24 hours. • Maintenance dose 250mcg (0.25mg) daily • In non urgent situations; Tab loading dose 0.5mg- 1mg orally daily in 2-3 divided doses for 2-3days • Maintenance dose 250mcg orally daily and elderly patients 125mcg daily (15mcg/kg) daily for 5 days • NOTE: Ensure patient has not been taking digoxin in the past 14 days before digitalizing because of risk of toxicity due to accumulation in the tissues. • ACE inhibitors e.g Captopril, Enalapril, Lisinopril
  • 27. Mgt of HF/CCF • Tab Captopril 6.25mg tds, starting dose then Maintenance dose of 50mg tds • For acute pulmonary oedema (severe chest pain) e.g Morphine 5-15mg (0.1mg/kg) repeated every 4- 6 hours until there is improvement.
  • 28. HYPERTENSION=C.O X P.R PRESENTATION OUTLINE 1. Definition 2. Risk factors/Causes 3. Classification of HTN 4. Types of HTN 5. Signs and symptoms 6. Investigations 7. Hypertensive emergency 8. Hypertensive crisis 9. Management 10.Complications
  • 29. Definition HTN is persistent elevation of blood pressure higher than normal for a patient's age.  The elevation may occur during systolic phase (when the heart is in contractile phase) or during the diastolic phase (when the heart is in relaxation phase). Generally a sustained BP of 140/90mmHg and above indicate HTN. HTN can also be defined as persistent high resting blood pressure.
  • 30. Causes • Un known/idiopathic (majority of cases)-essential HTN Secondary causes Chronic glomerulonephritis, Pyelonephritis Eclampsia and preclampsia (pregnancy) Renal failure Drugse.g oral contraceptives&steroids Cushing’s syndrome Coarctation of the aorta Phaeochromocytoma Alcohol intoxication Primary aldosteronism Renal vascular diseases
  • 31. Risk factors of HTN Old age(>60 years) DM Hyperlipidemia Obesity/over weight, High sodium intake Smoking Stress Family history of CVS diz Sedentary life style/lack of exercises Execessive alcohol intake See HF/CCF for more
  • 32. Classification of BP/HTN Systolic (mmHg) Diastolic (mmHg) Category <130 <80 Normal <90 <60 Hypotension 130-139 81-89 High normal (pre HTN) 140-159 90-99 Mild HTN (stage 1) 160-179 100-109 Moderate HTN (stage 2) 180-209 >110 Severe HTN (stage 3) >209 Very severe HTN (stage 4)
  • 33. Types of HTN 1. Essential HTN (primary HTN) Most common and cause not known Contributes to 90-95% of the cases of HTN in medical practice. 2. Secondary HTN Elevation of BP due to an identifiable cause e.g see above. There is poor response to RX (resistant HTN), worsening control in previously stable patients, systolic BP of >180mmHg, or diastolic of >110mmHg, no family H/O HTN, onset of HTN < 20 years, significant hypertensive target organ damage.
  • 34. Types of HTN cont’d • Secondary HTN accounts for 5-10% • Primary HTN affects both sexes equally ratio 1:1 • Primary HTN often seen in later years of life and usually has familial history. • If both parents were/are suffering from HTN, there is 45% chances of their children suffering from HTN • Severity of HTN increases gradually but can be acute or progressive with a poor prognosis known as malignant HTN
  • 35. Signs and Symptoms of HTN • There is no s/s specific to HTN instead it is diagnosed by chance during routine medical examinations. S/S include • Headache Anxiety • Palpitations Nervousness • Breathlessness/DIB • Dizziness Weight loss • Chest pain Insomnia • Epistaxis Irritability • Wheezing
  • 36. Complications of HTN • Some patients may present with symptoms associated with complications The include; Stroke (Brain) Renal failure (Kidney)=oliguria Impaired vision/blurred vision (Eyes) Heart failure (Heart)=oedema, DIB, Orthpnoea Heart attack Hypertensive encephalopathy=fits/convulsions, vertigo, impaired memory and concentration
  • 37. Investigations FBC/CBC Chest X-ray Fasting blood sugar (FBS) Urinalysis ECG/ECHO RFTs Serum uric acid Total, high and low density lipoprotein cholesterol
  • 38. Management of HTN Aim of Rx To normalize BP to less than 140/90mmHg To avoid hypotension and to improve survival To avoid adverse drug effects To prevent or retard end-organ damage Supportive Mgt Sodium restriction (reduce salt intake) Weight reduction if patient is obese Regular aerobic exercises (little jogging) Behavioral modification to reduce stress
  • 39. Supportive MGT cont’d Restriction of alcohol Avoidance of smoking Increased consumption of fruits and vegetables Re-evaluate patients after4-6weeks and if still hypertensive, then drug RX is recommended Patient education is important as non compliance is a major cause of poor response to RX Appropriate counseling and patient follow up is needed to understand the risk of untreated HTN. This mgt is for mild HTN
  • 40. Drug mgt=moderate-severe HTN • Drug combination is important in mgt of HTN 1. Angiotensin enzyme converting inhibitors (ACEI) e.g captopril 25-50mgtds, Lisinopril 5mg, Enalapril 2. Beta blockers e.g Carvedilol, Atenolol, propranolol 3. Calcium channel blockers e.g Nifedipine, Amlodipine, Felodipine 4. Diuretics e.g Bendrofluazide, Furosemide, Sprinolactone 5. Angiotensin-II antagonist e.g Losartan and Valsartan 6. Centrally-acting anti-HTN e.g Methylodopa
  • 41. Drug mgt cont’d • Tab Atenolol 50-100mg od/bd prn • Tab Propranolol 40mg-120mg bd/tds • Tab Carvedilol 3.125mg-6.25mg od/bd • Tab Furosemide 40mg-80mg od in morning (1mg/kg) • Tab Sprinolactone (Aldactone A) 25mg-50mg od/bd • Tab Bendrofluazide 2.5mg-5mg od morning • Tab Nifedipine 20mg-40 bd/tds • Tab Amlodipine 5mg-10mg bd • Tab Losartan 50mg od/bd • Methylodopa 250mg bd/tds
  • 42. Drug mgt cont’d • AB/CD/BC/ABC/BCD can be used • Propranolol, atenolol should not use in heart failure and asthma • Diuretics should not use in pregnancy or breast feeding except in case of pulmonary oedema or pre- eclampsia. • Make notes about suitability safety of ant hypertensive in different conditions like DM,CCF,COPD/Asthma, Ischaemic heart diseases, Chronic renal failure etc
  • 43. Hypertensive crisis • This is a group of acute hypertensive disorders characterized by end organ damage (180/120mmHg). • In hypertensive crisis, arterial BP rises rapidly and severely, threatening the patient's life and can quickly comprises the patient's cerebral, cardiovascular and renal function. • Non compliance and rebound HTN following withdrawal of RX should always be considered as an etiological factor. Classification of Hypertensive crisis • Hypertensive urgency and emergency
  • 44. Hypertensive urgency • This is a clinical situation in which there is an elevation of blood pressure but end organ damage is less acutely progressive (gradual). • Hypertensive urgency is less life threatening. Signs and symptoms • Severe headache • Nausea and vomiting • Dyspnoea • Blurred vision • Chest pain, leg & arm numbness &tingling • Progressive impairment of consciousness
  • 45. Mgt of hypertensive urgency • Nifedipine, Captopril and Prazosin Hypertensive emergency This is a clinical situation in which there is an elevation of BP complicated by life threatening end organ damage (acute). Situations in which HTN is considered an emergency are; Hypertensive encephalopathy Acute aortic dissection Stroke Pulmonary oedema Acute MI, unstable angina Pre-eclampsia and Eclampsia
  • 46. Mgt of hypertensive emergency • It requires rapid (within one hour) lowering of BP to prevent any organ damage. • Admit a patient • IV furosemide 40-80mg stat • Iv hydralazine 20mg slowly in D5% over 20minutes • Check BP regulary at least 3 hourly • Rapidly acting antihypertensive e.g sodium nitroprusside, hyralazine (Apresoline) and Labetalol are normally used.
  • 47. ISCHEAMIC HEART DISEASES (IHD) 1. Angina pectoris 2. Acute myocardial infarction NOTE: IHD can also be called Coronary heart disease (CHD)
  • 48. ANGINA PECTORIS This is a syndrome characterized by discomfort that occurs when the myocardial oxygen demand exceeds supply. A clinical syndrome as result of coronary blood flow being less than required hence lack of 02 in heart muscle. Transient myocardial ischemia Signs and symptoms Chest pain Dizziness Nausea Shortness of breath Left arm discomfort Sweating
  • 49. S/S cont’d Chest tightness in the middle of the chest like a band around chest. Sense of oppression worsening on exertion, relieved by rest and lasting for a few minutes. Pain radiates to left hand and neck& is more induced after meals and cold weather. Pain is also induced by exercise and relieved by rest Pain is likely to be worse when walking against wind or uphill/cold weather/after meals Some patients are wakened up by pain(nocturnal angina) with alarming dreams
  • 50. S/S cont’d Some patients experience pain when lying flat (angina decubitus) Pulse is weak and irregular, lasts for several hours Patient may go into shock, Dyspnoea Anxiety sweating, vomiting Low BP Arrhythmias
  • 51. Differential diagnosis Indigestion Peptic ulcer disease Pleurisy Pericarditis Severe anaemia Dissecting aneurysm (Separation of layers of aorta plus dilatation)
  • 52. Risk factors of Angina Advanced age DM Oral contraceptives Gender (males are more prone) HTN (especially when systolic BP>180mmHg) Calcium channel blockers e.g amlodipine Obesity Smoking Hyperlipidemia Hypothyroidism
  • 53. Classification of Angina Stable angina Unstable angina Prinzmetal’s angina Stable angina (Chronic stable angina) Usually precipitated by exertion and relieved by rest Frequency, intensity & duration of attack are stable Usually followed by precipitating factors e.g Climbing stairs A heavy meal Sexual intercourse Cold weather Emotional stress
  • 54. • Caused by a fixed coronary obstruction secondary to atherosclerosis. Unstable angina (coronary syndrome) Unstable angina is a clinical syndrome intermediate between stable angina and acute myocardial infarction. Characterized by Recent onset Increasing severity, duration or frequency of attacks It occurs at rest or with minimal exertion It may be due to plaque rupture
  • 55. Prinzmetal’s angina Occurs spontaneously when the patient is at rest with greater frequency during the night or early hours in the morning. It carries considerable risk of progression to myocardial infarction. It is caused by coronary artery spasm with or without significant coronary artery disease. Patients are also more likely to develop ventricular arrhythmias. It is common in women over 30 years .
  • 56. Supportive mgt Weight reduction in obese patients Regular aerobic exercises Correction of folate deficiency Low cholesterol/low fat and low sodium intake Advise the patient to stop smoking Correction of possible aggravating factors e.g anemia, HTN, DM, hyperlipideamia etc Monitor closely pulse rate and circulatory status Effective control of HTN and DM
  • 57. Drug mgt Nitrates e.g Sublingual nitroglycerine and isosorbide dinitrate Glyceryl trinitrate 500mcg sublingually, repeat after 5min if no response Beta blockers e.g atenolol, propranolol 10-40mg prn Avoid it patinets with shock or hypotension Calcium channel blockers e.g nifedipine, amlodipine Acetylsalicyclic acid 150mg single dose 2 be chewed
  • 58. MYOCARDIAL INFARCTION (MI) 1. Definition 2. Cause 3. Risk factors 4. Signs and symptoms 5. Investigations 6. Management
  • 59. Definition This is necrosis of heart muscles resulting from an insufficient supply of oxygenated blood to an area of the heart. It results from occlusion of a coronary artery by a thrombus supplying that area. OR it is a condition in which part of myocardium is damaged due to a major obstruction in the coronary artery that part of the heart gets insufficient blood supply and dies off. The infarct may affect full thickness of the myocardium or it may be confined to sub endocardial region.
  • 60. Aetiology/cause Coronary thrombosis is the main cause due to arteriosclerosis. It always due to formation of an occlusive thrombus at any site in the coronary artery.  The thrombus often undergoes spontaneous lysis over the next 2days although at this time myocardial damage has already occurred.
  • 61. Risk factors of MI Cigarette smoking Obesity DM Family history of heart disease HTN Excessive alcohol intake Previous cardiovascular disease e.g angina pectoris Plasma lipid abnormalities/high cholesterol levels Old age
  • 62. Signs and symptoms of MI Weakness/fainting/extreme fatigue Bradycardia Sweating Severe tight chest pain lasting more than 20minutes Patient usually restless and in severe pain Low BP (hypotension) Bilateral crackle in the chest Shortness of breath/dyspnoea Feeling of indigestion Nausea and vomiting
  • 63. S/S cont’d Pain is more described as tightness or heaviness or constriction in the chest At its worst, pain is one of the most severe pain to be experienced by a patient in which pallor may convey the seriousness of the situation. Cyanosis may occur Vomiting and sinus Bradycardia may be due to vagus nerve stimulation but vomiting can also be aggravated by opiate analgesics. Patient may have fever and die off in a few days.
  • 64. Investigations ECG/ECHO Fasting blood sugar FBC/CBC Serum lipid profile Cardiac enzymes Blood urea and creatinine (RFTs) DDX Angina pectoris Pericarditis Mitral valve stenosis
  • 65. Complications of MI Heart failure due of impaired contraction of the myocardium Rupture of the heart Severe arrhythmias Pulmonary embolism Pulmonary infarction Pericarditis
  • 66. Management of MI Aims of mgt To abort infarction To increase myocardial oxygen delivery To provide symptomatic relief of pain and reduce anxiety To prevent complications and recurrences To reduce mortality and improve the quality of life To rehabilitate the patient and also prevent arrhythmias
  • 67. Mgt of acute attack of MI Morphine IV 5mg-10mg to relieve pain and anxiety Oxygen therapy to all patients except those with COPD Nitrates e.g Glyceryl trinitrate 500mcg sublingually, repeated after 5min if no response to relieve Ischaemic pain Aspirin 75mg-150mg (cardiac aspirin/Ecorin 75mg) to dissolve the clots or other antiplatelets Metoclopramide 5-10mg IV/IM may be added to prevent nausea and vomiting associated with morphine Always remember MONA in AMI
  • 68. Long term mgt of MI Supportive mgt Control of HTN Rest and reassurance Avoid smoking Exercises regularly should be mild during the period when infarct is replaced by a fibrous tissue 4-6wks Reduce weight for obese patients Proper control of DM Avoid sedentary lifestyles Eating vegetables and fruits Avoid fatty diet
  • 69. Long term drug mgt of MI Aspirin 75mg-150mg daily (prolonged use) by mouth to reduce the rate of reinfarction Beta blockers e.g atenolol 5mg-10mg or propranolol should be continued for at least one year (for arrhythmias) Nitrates may be required for patients with angina Statins e.g simvastatin may be used in patients with high risk of reoccurrence Thrombolytic drugs e.g IV streptokinase 1.5mu in 100mls of N/S as an infusion over 1 hour is useful in acute attacks.
  • 70. STROKE (CVA) PRESENTATION OUTLINE 1. Definition 2. Classification 3. Causes 4. Risk factors 5. Symptoms and signs 6. Investigations 7. Management
  • 71. Definition and classification of stroke This is acute brain injury caused by decreased blood supply or heamorrhage. Stroke is a medical emergency and can cause permanent neurological damage, complications and death if not promptly DX and RX. Classification of stroke 1. Ischaemic stroke (lack of blood supply caused by thrombosis or embolism) 2. Haemorrhagic stroke
  • 72. Causes of stroke Blood clot (embolism from distant site) Cardio-embolic stroke accounting for 20-25% of all stroke Cerebral heamorrhage (secondary to HTN) Clotting with in the artery (Thrombosis)
  • 73. Risk factors of stroke Hypertension Cigarette smoking Excessive alcohol intake Undesirable blood cholesterol (LDL/HDL) DM Obesity Old age
  • 74. Signs and symptoms of stroke Sudden onset of weakness or numbness of the face, arm or leg Sudden lack of coordination of the limbs Sudden vision loss or double vision Sudden difficult in speaking Severe dizziness Loss of balance Severe headache Paraplegia/hemiplegia/monoplegia Coma Muscle weakness/paresis
  • 75. Investigations Fasting blood sugar Urinalysis FBC/CBC Serum triglycerides and cholesterol (lipid profile) Chest/skull x-ray ECG and ECHO CT scaninng
  • 76. Management of stroke Supportive mgt Admit the patient if unable to walk Ensure adequate oxygenation Ensure adequate fluid and electrolyte balance Prevent pressure sores by regular turning of the patient, Pass Nasogastric tube for feeding Pass urethral catheter to keep patient clean Physiotherapy should be started as soon as BP stabilizes Prophylactic anticoagulants to prevent thromboembolism
  • 77. Drug mgt Acute stroke (Ischaemic/haemorrhagic) Antiplatelet Rx e.g Aspirin 150mg-300mg started with in 48hours of the onset of Ischaemic stroke IV Clexane 40iu od/bd Anticoagulants e.g Heparin Anticoagulants and antiplatelets drugs are not used in the mgt of hemorrhagic stroke as they may exacerbate bleeding The main treatment in this type of stroke is to normalize HTN
  • 78. Long term mgt of stroke Adequate control of HTN, DM, Hyperlipidemia e.g artovastastin tab 10mg increase after 4weeks max 40mg/day, simvastatin Reduction of alcohol consumption Advise the patient to stop smoking Tab Aspirin 75mg-150mg daily prn Tab Dipyridamole 300mg-600mg in 3-4 divided doses OR Tab Clopidogrel initially 300mg then 75mg od